The rise of copyright’s blockbuster initially fueled a boom for pharma, nevertheless recent shifts present a uncertain picture for shareholders. Generic competitors are reducing profits, and ongoing patent challenges https://hamzahdunn280749.blogpostie.com/62395893/sildenafil-and-pharma-a-volatile-play